Christopher Chen

Stock Analyst at Robert W. Baird

(2.92)

# 2,635

Out of 4,581 analysts

Total ratings

100%

Success rate

63.5%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Christopher Chen

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	LRMR Larimar Therapeutics	Maintained: Buy	$5	$3.83	+30.55%	1	Jun 30, 2026
	DFTX Definium Therapeutics	Maintained: Buy	$37 → $57	$41.96	+35.84%	2	Jun 23, 2026

Larimar Therapeutics

Jun 30, 2026

Maintained: Buy

Price Target: $5

Current: $3.83

Upside: +30.55%

Definium Therapeutics

Jun 23, 2026

Maintained: Buy

Price Target: $37 → $57

Current: $41.96

Upside: +35.84%